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Abstract PICOT
Background Information 
• Time period of research study was from 2001 through 
2012, but extensive preventative measuers were not 
put into place until 2006
• The sample used in this research study was the 6565 
admissions to the ICU at Medway Maritime hospital in 
Gillingham, UK
• MRSA infection obtained 48 hours or less in ICU was 
considered community acquired
• MRSA infection on the 5th day or later in the ICU was 
considered hospital acquired
• Daily bathing with chlorhexidine 
• Environmental decontamination- Deep cleaning of ICU
• MRSA screenings upon admission- nasal and groin 
swabs
• Isolation precautions for positive patients
• Eradication therapy- topical and oral antibiotics used 
together
• Strict hand hygiene
Methods/Materials
References
Pittsburg State University 
Brody Wild, Senior BSN Student 
Barbara McClaskey, Faculty 
Stop the Potential Killer: Prevention of Methicillin-Resistant Staphylococcus Aureus (MRSA)
Population: Intensive care patients
Intervention: Increase infection control in ICU setting
Comparison: Standard care/ no extensive measures 
Outcome: Decreased hospital acquired MRSA infections 
Time: Length of stay in the ICU
Fukunaga, B. T., Sumida, W. K., Taira, D. A., Davis, J. W., & Seto, T. B. (2016, October). 
Hospital-Acquired Methicillin-resistant Staphylococcus aureus Bacteremia Related to 
Medicare Antibiotic Prescriptions: A State-Level Analysis. Retrieved October 24, 2018, 
from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056633/
Humphreys H., & Grundmann H. (2014, December 12). Prevention and control of 
methicillin-resistant Staphylococcus aureus. Retrieved October 24, 2018, from 
https://www.sciencedirect.com/science/article/pii/S1198743X14604237
Thompson, D. S., & Workman, R. (2014). Hospital-wide infection control practice and 
Meticillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU): An 
observational study. JRSM Open, 5(10), 205427041454714. 
doi:10.1177/2054270414547145
William, J. R. (2010, January 15). Prevention and Control of Methicillin-Resistant 
Staphylococcus aureus : Dealing With Reality, Resistance, and Resistance to Reality. 
Retrieved October 24, 2018, from 
https://academic.oup.com/cid/article/50/2/218/329489
16, M. (2017, November 22). New Research Estimates MRSA Infections Cost U.S. 
Hospitals $3.2 Billion to $4.2 Billion Annually. Retrieved October 24, 2018, from 
https://www.infectioncontroltoday.com/infections/new-research-estimates-mrsa-
infections-cost-us-hospitals-32-billion-42-billion-annually
The risk for hospital-acquired methicillin-resistant 
staphylococcus aureus (MRSA) infections in the ICU is 
great considering the length of stay and the invasive 
procedures most patients go through. MRSA infections 
may lead to death and contribute greatly to the cost of 
care. The purpose of this study was to examine the 
evidence for the best possible means of preventing 
MRSA. The methodology was a review of the current 
research. Some of the measures that were found to be 
beneficial included daily bathing with chlorhexidine, 
environmental decontamination, MRSA screenings upon 
admission, isolation precautions for positive patients, 
eradication therapy, and strict hand hygiene. Conclusions 
indicate that hospital acquired MRSA infections can be 
decreased with strict adherence to the correct regimen 
and continuous, hospital-wide education and awareness.
Results/Conclusion
• From the year 2006 and on, there was a 
significant decrease in the number of patients 
that became infected after the first five days in 
the ICU. 
• This was due to early detection and eradication 
therapy to positive patients 
• Results showed that after extensive measures put 
into place, most ICU acquired MRSA infections 
were caused by known positive patients admitted 
to the ICU
• This shows that after additional measures are 
taken, hand hygiene seems to be the biggest 
contributing factor
Purpose
The purpose of this study was to measure whether the 
implementation of extensive preventative measures in 
the ICU and hospital wide would lead to a decrease in the 
amount of hospital acquired MRSA infections in the ICU. 
• The risk for Hospital acquired MRSA infections in the 
ICU is great considering the length of stay and the 
invasive procedures most patients go through
• “(MRSA) alone results in almost half of all deaths 
caused by antibiotic resistant organisms”(Fukunaga).
• A 2005 study states, “The annual nationwide cost to 
treat hospitalized patients with methicillin-
resistant Staphylococcus aureus (MRSA) infections is 
estimated to be between $3.2 billion to $4.2 
billion”(Pfizer Inc. 2005.).
